1. Presentation
on
RECORDS & REPORTS
Presented by;
Ashok Kumar
B.Pharm 8thsem.
VBS Purvanchal University Jaunpur

2.  RECORDS AND REPORTS
 INTRODUCTION:
The Pharmacists must establish and maintain adequate record keeping
system. Various records must be retained and be retrievable by the
pharmacy because of governmental regulation. Some are advisable for
legal protection, other are needed for Joint Commission on
Accreditation of hospital (JCAH), and still other are necessary for
sound management evaluation of productivity, workloads and expenses
and assessment of department growth and progress of the pharmacy
department.

3.  It is important that pharmacist must study federal, state, and local
laws to becomes familiar with their requirements for permits, tax
storage of alcohol and controlled substance, records and reports.
 Following are The Records:
 1) Controlled substance inventory and dispensing records.
 2) Records of medication orders and their processing.
 3) Manufacturing and packaging production records.
 4) Purchase and inventory records.
 5) Pharmacy workload records.

4.  Recording and Filling of Prescription:
 A records of prescriptions dispensed is maintained in the
pharmacy through the use of computer and hard copy prescription
files. Newer centralized computer systems used by many chain
drug stores allow pharmacists from any place in the system to
access a patient’s records and refill a prescription previously
dispensed at another store.
 Suitably partitioned drawers sometimes are used for filing. The
method permits the removal of a single prescription

5.  Requirements for Prescription Filing for Controlled
Drug:
 1) Be completely written in the prescriber’s handwriting in ink
 2) Be signed and dated by the prescriber.
 3) Specify the prescriber’s address.
 4) Specific the name address of the patient.
 5) State the form and strength of the drug.
 6) State the total quantity of the drug or the number of dose units
to be dispensed in both words and figures.
 7) State the exact size of each dose in both words and figures.

6.  Importance of prescription Filling Records
 1) It Provides closer control of inventory.
 2) It Provides closer liaison among pharmacist, physician, nurse
and the patient in the medication matters.
 3) Name, age and sex of the patient,
 4) OPD or the registration no.
 5) Date.
 6) Name of drug.
 7) Strength of the drug.
 8) Dosage form

7.  DRUG PROFILE
 It is defined as an outline or summary of the
characteristics of a drug or drug family, listing dosage
type, pregnancy category, prescription or over-the-counter
forms, generics if available contraindications, and
classification if covered by controlled substance laws.
 Example: drug profile of Duloxetine

8. DULOXETINE
 Description:
Cymbalta (duloxetine hydrochloride) is a selective Serotonin and
Nor-epinephrine Reuptake Inhibitor (SNRI) for oral administration.
 Indication & Usage:
Duloxetine is indication for the treatment of major depressive
disorder. The effectiveness of Cymbalta for longer term more than 9
weeks use has not been systematically evaluated in clinical trials. It
is also indicated for management of diabetic peripheral neuropathic
pain.

9.  Contraindications:
Any of Cymbalta inactive ingredients.
It should not be used Concomitantly with an MAOI.
 Precautions:
Cymbalta increase the rick of elevated serum transaminase.
It has been associated with an increase in blood pressure.
Blood pressure should be monitored throughout treatment.
It should not be used in those with uncontrolled narrow-angle
glaucoma.

10.  Warnings:
When dose changes are made patient should also be
monitored for the emergence of symptoms such as anxiety,
agitation, panic attacks, irritability.
 Pregnancy and Lactation:
Cymbalta is a class C drug. There are not adequate and well
controlled studies in pregnancy women. Therefore Duloxetine
should be used during pregnancy only if the potential benefit
justifies the potential risk to the foetus.

11.  Adverse effect:
Nausea, dry mouth, constipation, diarrhoea, Vomiting,
Weight loss, sexual side- effects
 Drug abuse and Dependence:
Duloxetine is not a controlled substance. In animal studies, it
did not demonstrate barbiturate like abuse potential. In drug
dependence studies.
 Dosage and Administration:
Cymbalta should be administration Total dose of 40mg/day

12.  Patient Medication Profile
 The Patient medication profile is one of the major
advantages of the unit dose system. The medication
profile gives pharmacy personnel the opportunity to
actively participate in monitoring patient care. The form
used for the profile is designed locally and vary from one
hospital to another, but the information contained on the
from should be similar.

13.  Sections of Patient Medication Profile
 1) Patient Information.
 2) Allergy Information.
 3) Diagnosis and Pre-Existing Conditions.
 4) Scheduled Medication.
 5) Non-Scheduled Medication.
 6) Floor stock / Ward stock Medication.

14.  Case of Drug Interaction
 Absorption Interaction
Object Drugs Precipitant Drugs Influence on object
Drugs
Tetracycline ,
ciprofloxacin
Antacids, food,
milk
Complex formation
Sulphonamide, aspirin Antacids Enhanced absorption rate
Digoxin Antibiotics Increased bioavailability

15.  Distribution Interaction
 Metabolism Interaction
Tolbutamide Sulphonamide Increase hypoglycemia
effect
Methotrexate Sulphonamide Increase methotrexate
toxicity
Phenytoin Valproic acid Phenytoin toxicity
Oral contraceptives barbiturate Decreased plasma level
Oral contraceptives Phenytoin Decreased plasma level
Oral contraceptives Rifampicin Decrease plasma level

16.  Excretion Interaction
Penicillin, PAS,
Dapsone
Probenicid Risk of toxic reaction
Ranitidine Cimetidine Risk of toxic effect
Amphetamine ,
tetracycline
Antacids Risk of toxicity effect